Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Indole-3-Carbinol Effects on Estrogen Metabolism

This study has been terminated.
(Slow accrual in the high BMI group)
Information provided by:
University of Wisconsin, Madison Identifier:
First received: October 1, 2009
Last updated: July 8, 2010
Last verified: July 2010

October 1, 2009
July 8, 2010
September 2009
October 2010   (final data collection date for primary outcome measure)
Change in urinary 2/16-hydroxyestrone ratio [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00988845 on Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Indole-3-Carbinol Effects on Estrogen Metabolism
Effects of Dietary Indole-3-Carbinol on Estrogen Metabolites Across a Wide Range of Body Mass Index: Implications for the Prevention of Endometrial Cancer in Obese Women

This study will test a dietary supplement, indole-3-carbinol, for improving the estrogen profile in women across a range of body mass index.

Not Provided
Phase 2
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Dietary Supplement: Indole-3-carbinol
200 mg bid po X 8 weeks
Experimental: Indole-3-carbinol
Intervention: Dietary Supplement: Indole-3-carbinol
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
October 2010
October 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • woman aged from 30 - 50 years
  • regular menstrual cycle

Exclusion Criteria:

  • taking hormone replacement or hormonal contraception
  • thyroid disorder
  • uncontrolled asthma
  • BMI under 18.5
  • allergy to cruciferous vegetables
30 Years to 50 Years
Contact information is only displayed when the study is recruiting subjects
United States
H-2009-0093, CC09709
Joseph P. Connor, MD, University of Wisconsin
University of Wisconsin, Madison
Not Provided
Principal Investigator: Joseph P Connor, MD University of Wisconsin, Madison
University of Wisconsin, Madison
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP